title: Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
authors.forename: H O
authors.initials: HO
authors.lastname: Guembel
authors.forename: F
authors.initials: F
authors.lastname: Hofmann
authors.forename: G
authors.initials: G
authors.lastname: van Even
authors.forename: J
authors.initials: J
authors.lastname: Cinatl
authors.forename: R
authors.initials: R
authors.lastname: Makabe
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D017245:Foscarnet / Q000008:administration & dosage / Q000627:therapeutic use*; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014822:Vitreous Body
chemical_list: D000998:Antiviral Agents; D017245:Foscarnet; D015774:Ganciclovir